RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer (Q44963911)
Jump to navigation
Jump to search
scientific article published on 7 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer |
scientific article published on 7 March 2011 |
Statements
1 reference
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer (English)
1 reference
1 reference
Denise A Yardley
1 reference
Joyce O'Shaughnessy
1 reference
Edith A Perez
1 reference
Nicholas J Robert
1 reference
Véronique Diéras
1 reference
John Glaspy
1 reference
Adam M Brufsky
1 reference
Oleg N Lipatov
1 reference
Stephen Y T Chan
1 reference
Xian Zhou
1 reference
See-Chun Phan
1 reference
7 March 2011
1 reference
1 reference
Identifiers
1 reference